These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12038698)

  • 41. Baseline predictors of end-stage renal disease risk in patients with type 2 diabetes and nephropathy: new lessons from the RENAAL Study.
    Shahinfar S; Dickson T; Zhang Z; Keane WF; Brenner BM;
    Kidney Int Suppl; 2005 Jan; (93):S48-51. PubMed ID: 15663528
    [No Abstract]   [Full Text] [Related]  

  • 42. Approach to the patient with type 2 diabetes and progressive kidney disease.
    Seaquist ER; Ibrahim HN
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3103-10. PubMed ID: 20610606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline: response to Burrows, Li, and Geiss.
    Villar E; McDonald SP; Couchoud C
    Diabetes Care; 2010 May; 33(5):e69; author reply e70. PubMed ID: 20427678
    [No Abstract]   [Full Text] [Related]  

  • 44. Diabetes, a cause of progressive sarcopenia in dialysis patients?
    Kaysen GA
    Kidney Int; 2005 Nov; 68(5):2396-7. PubMed ID: 16221246
    [No Abstract]   [Full Text] [Related]  

  • 45. Characteristics of elderly patients with diabetes and end-stage renal disease.
    Goldfarb-Rumyantzev AS; Rout P
    Semin Dial; 2010; 23(2):185-90. PubMed ID: 20374551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Incidence and clinical characteristics of renal insufficiency in diabetic patients].
    Schwenger V; Müssig C; Hergesell O; Zeier M; Ritz E
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1322-6. PubMed ID: 11719856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.
    Locatelli F; Aljama P; Bárány P; Canaud B; Carrera F; Eckardt KU; Hörl WH; Macdougal IC; Macleod A; Wiecek A; Cameron S;
    Nephrol Dial Transplant; 2004 May; 19 Suppl 2():ii1-47. PubMed ID: 15206425
    [No Abstract]   [Full Text] [Related]  

  • 48. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).
    Van Dijk PC; Jager KJ; Stengel B; Grönhagen-Riska C; Feest TG; Briggs JD
    Kidney Int; 2005 Apr; 67(4):1489-99. PubMed ID: 15780102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.
    Shrivastava D; Rao TK; Sinert R; Khurana E; Lundin AP; Friedman EA
    Am J Kidney Dis; 1995 Jun; 25(6):904-9. PubMed ID: 7771487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Chronic kidney disease--update 2015].
    Wanner C; Ketteler M
    Dtsch Med Wochenschr; 2015 Aug; 140(16):1216-8. PubMed ID: 26261930
    [No Abstract]   [Full Text] [Related]  

  • 51. [The importance of starting regular haemodialysis through a native arteriovenous venous fistula].
    Díaz Corte C; Gago González E; Ourens MJ; Ortega T
    Nefrologia; 2009; 29(2):177-8. PubMed ID: 19396329
    [No Abstract]   [Full Text] [Related]  

  • 52. The drumbeat of renal failure: symbiosis of prevention and renal replacement therapy.
    Dirks JH
    Blood Purif; 2004; 22(1):6-8. PubMed ID: 14732805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythropoietin-dependent anaemia: a possible complication of diabetic neuropathy.
    Hadjadj S; Torremocha F; Fanelli A; Brizard A; Bauwens M; Maréchaud R
    Diabetes Metab; 2001 Jun; 27(3):383-5. PubMed ID: 11431605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study.
    Afifi A; El Setouhy M; El Sharkawy M; Ali M; Ahmed H; El-Menshawy O; Masoud W
    East Mediterr Health J; 2004; 10(4-5):620-6. PubMed ID: 16335654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Increasing number of dialysis-requiring patients with diabetic nephropathies. Better diabetes control and antihypertensive treatment can counteract the trend].
    Kurkus J; Schön S; Prütz KG; Torffvit O
    Lakartidningen; 2005 May 2-15; 102(18-19):1420-3. PubMed ID: 15929425
    [No Abstract]   [Full Text] [Related]  

  • 56. [Neoplasias in chronic renal failure].
    Peces R; Garrancho JM
    Nefrologia; 2004; 24(1):40-6. PubMed ID: 15083956
    [No Abstract]   [Full Text] [Related]  

  • 57. Acquired perforating dermatosis in renal and diabetic patients.
    Farrell AM
    Lancet; 1997 Mar; 349(9056):895-6. PubMed ID: 9093247
    [No Abstract]   [Full Text] [Related]  

  • 58. [Chronic renal insufficiency and diabetics].
    Baguet JC; Alphonse JC; Gontier Y
    Bull Soc Ophtalmol Fr; 1977 Jan; 77(1):55-62. PubMed ID: 589759
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic possibilities in patients with terminal kidney insufficiency as a sequela to diabetic nephropathy].
    Jansen JL
    Ned Tijdschr Geneeskd; 1979 Jan; 123(4):117-24. PubMed ID: 368661
    [No Abstract]   [Full Text] [Related]  

  • 60. [Chronic renal failure: what has changed in the last two decades].
    Grünfeld JP
    Presse Med; 2011 Nov; 40(11):1018-9. PubMed ID: 21885238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.